Welcome
The CTRND is an innovative, multidisciplinary research center focused on the discovery, development and evaluation of future treatments and diagnostics for degenerative central nervous system conditions.
Our Mission
The CTRND’s mission is to discover, develop and evaluate future treatments and diagnostics for degenerative central nervous system conditions including Alzheimer’s disease, Parkinson’s disease, stroke and other neurodegenerative brain disorders.
Recent News
Research Snapshot: Drs. Malú Gámez Tansey …
New research illuminates how loss of the protein progranulin may influence immune system function in the brain and periphery in aged mice. The…
Congratulations to Drs. Abisambra and Chakrabarty…
CTRND congratulates two of our primary faculty, Dr. Joe Abisambra and Dr. Paramita Chakrabarty, for earning tenure through the Neuroscience…
Article by Doré lab team explores effects of…
The article represents a team effort by undergraduate and graduate students that was initiated during the COVID-19 pandemic. It provides a detailed…
College Calendar
Upcoming Events
-
Mar 29
-
AD/PD 2023
Gothenburg, Sweden
All Day
-
-
Mar 30
-
AD/PD 2023
Gothenburg, Sweden
All Day
-
-
Mar 31
-
AD/PD 2023
Gothenburg, Sweden
All Day
-
-
Apr 01
-
AD/PD 2023
Gothenburg, Sweden
All Day
-
-
Apr 03
-
CTRND Faculty Meeting
9:30am to 10:30am
-
-
May 01
-
CTRND Data Seminar
9:30am to 10:30am
-
-
May 07
-
Parkinson Gordon Conference (GRC)
Switzerland
All Day
-
-
May 08
-
Parkinson Gordon Conference (GRC)
Switzerland
All Day
-
-
May 09
-
Parkinson Gordon Conference (GRC)
Switzerland
All Day
-
-
May 10
-
Parkinson Gordon Conference (GRC)
Switzerland
All Day
-
-
May 11
-
Parkinson Gordon Conference (GRC)
Switzerland
All Day
-
-
May 12
-
Parkinson Gordon Conference (GRC)
Switzerland
All Day
-
-
Jun 05
-
CTRND Faculty Meeting
9:30am to 10:30am
-
1Florida ADRC
Deadline: Developmental Project Grants
November 18 at 5 pm
Research proposals can span the spectrum of Alzheimer’s disease (AD) and AD related disorders -ranging from basic, clinical, translational, and health care outcomes and policy research, with particular attention given to novel approaches. Research projects may involve humans, data mining, model systems, preclinical therapeutic development or in vitro studies. Clinical trials are not allowed. Though we will not have a formal LOI process, we strongly encourage prospective applicants to discuss both eligibility and the project with 1Florida ADRC investigators and the director (tgolde@ufl.edu) prior to submission. Total direct budgets up to $100,000/yr will be considered.
